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Here we show that gene expression of the nuclear receptor RORa is induced during adipogenesis,
with RORa4 being the most abundantly expressed isoform in human and murine adipose tissue.
Over-expression of RORa4 in 3T3-L1 cells impairs adipogenesis as shown by the decreased expres-
sion of adipogenic markers and lipid accumulation, accompanied by decreased free fatty acid and
glucose uptake. By contrast, mouse embryonic ﬁbroblasts from staggerer mice, which carry a muta-
tion in the RORa gene, differentiate more efﬁciently into mature adipocytes compared to wild-type
cells, a phenotype which is reversed by ectopic RORa4 restoration.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
White adipose tissue is a central organ for whole-body energy
homeostasis. It serves as a buffering depot for excess energy and
releases fatty acids upon energy demand [1]. Adipose tissue is also
an endocrine organ which secretes numerous adipokines such as
leptin and adiponectin, and cytokines such as TNFa, which regulate
(patho)physiological processes such as insulin sensitivity, inﬂam-
mation or food intake. Several transcription factors act in concert
to orchestrate the differentiation of pre-adipocytes into adipocytes
[2]. Peroxisome Proliferator-Activated Receptor c (PPARc) and
CCAAT/enhancer-binding proteins (CEBP) a, b and d are master
regulators, which trigger a cascade of transcriptional events hence
initiating differentiation and instoring the mature phenotype. Re-
cent evidence however indicates that this process can be modu-
lated positively and negatively by other pathways [3]. For
example, we and others have shown that Rev-erba, a nuclear
receptor regulating lipid and bile acid metabolism, the inﬂamma-
tory process and a core clock machinery gene [4], plays also a mod-
ulatory role in the regulation of adipogenesis [5,6]. Indeed, Rev-
erba gene expression is induced during the adipogenic processchemical Societies. Published by E
Institut Pasteur de Lille, BP
20 87 73 60.
ls).
rk.[5,7] and ectopic Rev-erba expression in 3T3L1 pre-adipocytes
promotes their differentiation into mature adipocytes and en-
hances lipid storage [5].
The RAR-related orphan receptors (RORs) are nuclear receptors
closely related to the Rev-erbs. Rev-erba and RORa are co-ex-
pressed in many tissues. In general, they compete for binding to
speciﬁc monomeric response elements (RevRE/RORE) hence acting
as a ying/yang loop to regulate common target genes in an oppo-
site manner (RORa acts as an activator, whereas Rev-erba as a
repressor) [8–10]. For instance, RORa regulates the expression of
several Rev-erba target genes, thereby playing a role in circadian
rhythm maintenance and plasma lipid control [11–17]. RORa also
plays a role in muscle lipid metabolism [18], and controls the
expression of the gluconeogenic glucose-6-phosphatase gene [19].
Here, we have investigated the role of RORa in adipogenesis and
report that RORa is a potent inhibitor of adipocyte differentiation.2. Materials and methods
2.1. Animals
Inguinal and epididymal fat depots were from wild-type C57BL/
6 mice. See Supplementary data for details.
Animal care and experimental procedures were performed
according to approved institutional guidelines.lsevier B.V. All rights reserved.
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Human fat tissue samples were obtained from healthy adult do-
nors, in agreement with French regulations. All subjects gave writ-
ten informed consent prior sample collection.
2.3. Viral production and infection
To generate cell lines that constitutively over-express RORa4,
the coding sequence of human RORa4 was inserted in the MFG ret-
rovirus plasmid [20] to generate the pMFG-RORa4 plasmid. A sim-
ilar construct lacking the RORa4 sequence (pMFG-Neo) was used
throughout the study as a negative control. Phoenix cells were
transfected with these constructs and selected for resistance using
the geneticin analog G-418. 3T3-L1 cells were infected with the
supernatant from MFG-Neo or -RORa4 infected cells, and G-418-
resistant infected cells were used within three passages after infec-
tion. See Supplementary data for details.
2.4. Cell culture and differentiation
3T3-L1 cells (ATCC) and MFG-Neo or -RORa4 infected 3T3-L1
cells were cultured and differentiated as previously described
[21]. See Supplementary data for details.
2.5. MEF isolation and culture
Mouse embryonic ﬁbroblasts (MEFs) were derived from 13.5-
day wild-type and staggerer mouse embryos. Adipocyte differenti-
ation was initiated after 2 days conﬂuence. MEFs were differenti-
ated with AmnioMAX-C100 medium (Invitrogen), 7.5%
AmnioMAX-C100 supplement, 7.5% fetal calf serum, 0.5 mM IBMX,
1 lM dexamethasone, 5 lM insulin. From day 3 to day 8, cells were
incubated with the same AmnioMAXC100 medium with 5 lMhRORα1 hRORα4
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Fig. 1. RORa1 and RORa4 are expressed in adipose tissue and differentiating adipocytes
differentiating 3T3-L1 cells. (C) mRNA levels were corrected to an internal control (cy
triplicate. (A) and (B) RORa1 expression in human visceral and mouse epididymal adipos
fold induction of their respective expression level at day 0 set as 1 (absolute Ct values iinsulin. At days 0 and 8, cells were lysed and homogenized for
RNA isolation or ﬁxed in 4% paraformaldehyde and stained with
Oil-red-O.
2.6. FFA uptake assay
Free fatty acid (FFA) uptake was measured using the commer-
cially available QBT Fatty Acid Uptake Assay Kit (Molecular Devices,
USA) as per the manufacturer’s instructions. See Supplementary
data for more details.
2.7. Glucose uptake
Assays were performed as described previously [21]. See Sup-
plementary data for details.
2.8. Gene expression
Total RNA was extracted from tissues or cells and retro-tran-
scribed as described earlier [21]. Gene expression was quantiﬁed
by quantitative RT-PCR on a Mx4000 apparatus (Stratagene, La Jol-
la, CA) using speciﬁc oligonucleotides as described in the Supple-
mentary data. mRNA levels were corrected to an internal control
(cyclophilin) and expressed as mean ± S.D.
2.9. Western blotting
See Supplementary data.
2.10. Statistics
All values are presented as mean ± S.D. Comparison between
two groups was performed by student’s t-test. Comparisons among0
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Fig. 2. RORa4 over-expression impairs differentiation of 3T3-L1 pre-adipocytes. RORa4 mRNA (A) and protein (B) levels in 3T3-L1 over-expressing RORa4 (MFG-RORa4) vs
control cells (MFG-Neo). Oil-red-O staining (C) and mRNA levels of PPARc, CEBPa, aP2 and SREBP1c/ADD1 (D–G) upon differentiation. Difference between Neo and RORa4
over-expressing cells; #difference between day 0 and day 8. Gene expression levels were normalized to an internal control (cyclophilin) and expressed as mean ± S.D. They are
from two independent experiments, each realized in triplicate, and expressed as fold induction of the MFG-Neo cells at day 0, set as 1.
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Fig. 3. RORa4 suppresses glucose and free fatty acid uptake in adipocytes. Fatty acid (A) and glucose uptake (B), as well as mRNA levels of genes involved in these processes
(C–H) were measured in control and RORa4 overexpressing differentiated 3T3-L1 cells. Uptake data are from three independent experiments realized in triplicate. Gene
expression levels (mean ± S.D.) were expressed as in Fig. 2.
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Fig. 4. RORa-deﬁciency improves adipocyte differentiation and function. Oil-red-O staining (A), mRNA levels of genes involved in adipogenesis (B–D) and FA (E) and glucose
uptake (F) in differentiating MEFs isolated from staggerer (sg/sg) (n = 4) and wild-type (WT, +/+) (n = 4) mouse embryos. Results are from three independent wells (per
embryo) and expressed as fold induction of wild-type cells at day 0, set as 1. *Difference between wt and sg/sg MEFs; #difference between day 0 and day 8.
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Tukey post hoc analysis. #,*P < 0.05; ##,**P < 0.01; ###,***P < 0.001.
3. Results
3.1. RORa1 and RORa4 are expressed in adipose tissue and
differentiating adipocytes
Expression of the four RORa isoforms (RORa1–4) was analyzed
in both human and mouse visceral and subcutaneous adipose tis-
sue by quantitative PCR. RORa1 and RORa4 were abundantly ex-
pressed in these tissues, whereas RORa2 or RORa3 were not
detected (not shown). RORa4 mRNA levels were 10-fold higher
than RORa1 mRNA levels in both intra-abdominal and subcutane-
ous adipose tissues (Fig. 1A and B). In the 3T3-L1 adipocyte differ-
entiation model, both RORa1 and RORa4 mRNA levels increased
during differentiation, but RORa4 induction was much larger
(Fig. 1C). Because the PCR efﬁciency may differ between the two
pairs of primers, the absolute Ct values are given in Table S1.
3.2. RORa4 over-expression impairs differentiation of 3T3-L1
pre-adipocytes
To assess a potential role of RORa4 in adipocyte differentiation,
3T3-L1 pre-adipocytes stably over-expressing the full-length hu-man RORa4 (MFG-RORa4) or control cells (MFG-Neo) were gener-
ated. RORa4 expression was signiﬁcantly higher in MFG-RORa4
compared to MFG-Neo cells, both at the mRNA and protein level
(Fig. 2A and B). Oil-red-O staining visualization at different stages
during differentiation showed, as expected, time-dependent
enhancement of lipid accumulation in MFG-Neo cells (Fig. 2C).
Strikingly, a marked reduction in lipid accumulation was observed
in RORa4-overexpressing adipocytes (Fig. 2C). This impairment
was associated with reduced expression of several genes involved
in adipocyte differentiation, such as PPARc, CEBPa, aP2 and ADD1/
SREBP1 (Fig. 2D–G).
3.3. RORa4 suppresses glucose and free fatty acid uptake in adipocytes
The function of adipocytes in the control of lipid and glucose
homeostasis is well-established. Therefore, the inﬂuence of RORa4
on free acid fatty (FFA) and glucose uptake was tested in differen-
tiated 3T3-L1 cells. Compared to control cells, RORa4 over-
expressing adipocytes showed an impaired ability in insulin-stim-
ulated uptake of FFAs (Fig. 3A). Consistently, gene expression of
CD36 and FATP, two FA transporters induced during adipocyte dif-
ferentiation, was strongly reduced by RORa4 over-expression
(Fig. 3C and D). Similarly, RORa4 over-expression negatively regu-
lated expression of genes involved in de novo fatty acid synthesis
and glycerogenesis such as FAS, ACC and PEPCK (Fig. 3F–H). In
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Fig. 5. RORa4 restoration in RORa-deﬁcient MEFs abolishes the permissive effects of RORa-deﬁciency. Oil-red-O staining and mRNA levels of RORa4 and genes involved in
adipogenesis, FA and glucose uptake in differentiating MEFs isolated from wild-type (n = 2) and sg/sg (n = 2) mouse embryos and over-expressing RORa4 (sg/sg-MFG-RORa4)
or a control (sg/sg-MFG-Neo) construct. Results are from three independent wells (per embryo) and expressed as fold induction of wild-type cells at day 0, set as 1. Difference
between wt, sg/sg-MFG-Neo and sg/sg-MFG-RORa4 MEFs; #signiﬁcant difference between day 0 and day 8.
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stimulated glucose uptake in differentiated adipocytes (Fig. 3B),
an effect which was associated with a suppression of expression
of the glucose transporter Glut-4 (Fig. 3E). Overall, these observa-
tions indicate that RORa4-induced impairment of adipocyte differ-
entiation is accompanied by altered FA and glucose metabolism.
3.4. RORa-deﬁciency improves adipocyte differentiation and function
Next, we assessed whether RORa-deﬁciency modulates adipo-
cyte differentiation using MEFs from staggerer (sg/sg) mice which
carry a non-functional mutated RORa gene. MEFs from staggerer
mice display a more pronounced lipid accumulation indicative of
increased differentiation into adipocytes compared to MEFs from
their wild-type littermates (Fig. 4A). This increased ability of sg/
sg MEFs to accumulate lipids was associated with an increased
expression of several markers of adipocyte differentiation such as
PPARc, aP2 and CEBPa (Fig. 4B–D) or genes involved in fatty acid
and glucose uptake such as FATP and Glut-4 (Fig. 4E and F). RORa4
restoration in MEFs from sg/sg mice blocked the permissive effects
of RORa-deﬁciency on lipid accumulation and adipocyte differenti-
ation, as well as expression of the PPARc, CEBPa, aP2, FATP and
Glut-4 genes (Fig. 5).
4. Discussion
Previous studies have identiﬁed a role for RORa in cerebellum
development, immune function and circadian rhythmicity [11–13,22]. Recent reports have also outlined a function for RORa in
cholesterol and lipid metabolism [14,15,23]. In the present study
we show that the RORa1 and RORa4 genes are expressed in adi-
pose tissue and that RORa increases upon differentiation of pre-
adipocytes into adipocytes, identifying RORa4 as the principal iso-
form in adipose tissue. Moreover, RORa4 over-expression in 3T3-
L1 cells inhibits adipocyte differentiation, impairs fatty acid and
glucose uptake and reduces expression of genes known to be
involved in both adipocyte differentiation (including PPARc, CEBPa
and aP2) and function (such as FAS, PEPCK, and the fatty acid and
glucose transporters FATP, CD36 and Glut-4).
Staggerer mice carry a naturally occurring mutation in the li-
gand-binding domain of RORa, which results in the expression of
a non-functional RORa protein. These mice suffer from cerebellar
ataxia and have reduced locomotor activity [24]. These mice addi-
tionally exhibit altered cholesterol and triglyceride plasma levels
and increased susceptibility to atherosclerosis and angiogenesis
[15,25]. Interestingly, Muscat and co-workers have recently re-
ported that staggerermice display reduced fat depots and are resis-
tant to diet-induced obesity [26]. The authors attributed this defect
to alteration in lipid metabolism as a result of down-regulated
expression of SREBP1c, FAS, ABCA1 and ABCG5 in liver, and in-
creased expression of genes involved in oxidative metabolism in li-
ver and adipose tissue. However, altered locomotor and rearing
activity of these mice coupled to the fact that they need special
assistance for food and drink intake may also have impacted this
phenotype. We show that MEFs isolated from staggerermice differ-
entiate more pronouncedly into mature adipocytes compared to
2036 H. Duez et al. / FEBS Letters 583 (2009) 2031–2036MEFs isolated from wild-type littermates. This effect is speciﬁc to
RORa since the phenotype of sg/sg MEFs is reversed by RORa res-
toration. Thus, RORa4 is a potent negative regulator of adipocyte
differentiation and may as such play a role in body weight and en-
ergy homeostasis.
Although our experiments did not address the molecular mech-
anism(s) involved in the RORa-mediated inhibition of adipogene-
sis, several hypotheses can be put forward. Inhibition of
adipocyte differentiation may occur principally through inhibition
of positive regulators such as PPARc or CEBPa, or through the
induction of inhibitory factors like GATA, KLF2, CHOP or Wnt sig-
naling [3]. Alternatively, RORa may regulate other factors known
to inhibit adipocyte differentiation, for instance, through induction
of p21CYP1/Waf1 leading to growth arrest. Along this line, Rev-erba
acts as a p21 repressor in hepatic cells [27], and RORc induces
p21 in liver. Thus, RORamight act, at least in part, by up-regulating
p21 transcription in adipose cells. Another possible explanation
may lie in the recent observation that Rev-erba represses PPARc2
gene expression during adipocyte differentiation [6]. The fact that
RORa induces Rev-erba gene transcription ([28] and this report,
not shown) may constitute an additional potential mechanism
for adipogenesis inhibition by RORa.
Although future studies are necessary to further delineate
RORa-regulated pathways in adipose cells, our ﬁndings clearly
identify RORa4 as novel negative modulator of adipocyte differen-
tiation and function.
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